GlassScriptPhysician profile
Herman D Movsowitz
NPI 1124096763
$2,271.07
in general payments reported to CMS, 2019-2025
16 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,020 · 2020: $62.86 · 2021: $425 · 2022: $290 · 2023: $199 · 2024: $137 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $650.98 | 2019-2021 | |
| Amgen INC. | $234.50 | 2020-2023 | Repatha |
| Merck Sharp & Dohme LLC | $221.45 | 2021-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $182.88 | 2021-2024 | Jardiance |
| Pfizer INC. | $174.15 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $159.70 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $135.28 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $116.37 | 2020-2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $116.26 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $81.64 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $49.78 | 2019 | |
| Medtronic, INC. | $49.78 | 2024 | Linq II |
| Boston Scientific Corporation | $40.58 | 2019 | |
| Tactile Systems Technology INC | $21.12 | 2025 | Flexitouch Plus, Nimbl |
| Esperion Therapeutics, INC. | $20.03 | 2024 | Nexletol |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herman Movsowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.